6-cyclobutylpyridazin-3(2H)-one is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug compounds. Its unique structure makes it a valuable intermediate in creating molecules with potential therapeutic effects, especially in targeting enzymes or receptors involved in various diseases. Researchers explore its application in designing inhibitors for specific biological pathways, which could lead to treatments for conditions like inflammation, cancer, or neurological disorders. Additionally, its cyclobutyl group enhances the compound's stability and binding affinity, making it a promising candidate for further medicinal chemistry studies.